RxDoctor Payments Data

Ravia Bokhari, MD

Surgery · Phoenix, AZNPI 1497959589

Payments from drug & device makers

$1,709in general payments, 2019–2025

Across 37 payments — averaging $46.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$978
  • Merck$187
  • Medtronic$155
  • Focal Therapeutics, Inc.$70
  • AbbVie$56
  • TELA Bio, Inc.$53
  • plus $209 from 9 others

What the payments were for

  • Food & beverage$1,27575%
  • Education$43425%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical9$978
Merck10$187
Medtronic2$155
Focal Therapeutics, Inc.1$70
AbbVie3$56
TELA Bio, Inc.1$53
Johnson & Johnson2$45
Acacia Pharma Inc2$31
Davol Inc.1$26
Baudax Bio Inc.1$22
Abbott1$19
Protega Pharmaceutials Inc1$17
Innovation Technologies Inc1$16
Northgate Technologies, Inc.1$16
Monaghan Medical Corporation1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,709 in reported general payments places this provider in the 50th percentile of 614 surgery providers in Arizona.

See all surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$48,937
Medicare patients
86
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl11$862
Oxycodone Hcl76$136
Prochlorperazine Maleate13$110

Paid to pharmacies, not to this prescriber.

Other surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →